CD8A and neoplasm: One arm of the BiAb binds to the target tumor-associated antigen and the other simultaneously binds CD3 on the surfaces of CD4+ helper T cells and CD8+ cytotoxic T cells, resulting in the formation of an immunological synapse that activates T cells without the need for T cell recognition of the MHC/antigen complex on tumor cells [10].